BDNF and Alzheimer disease: Apigenin has been found to possess neuroprotective properties in AD-associated inflammation by reducing microglial activation, modulation of expression of inflammatory cytokines, and increasing the expression of brain-derived neurotrophic factor (BDNF) in-vitro [99].